Control of blood pressure and low-density lipoprotein cholesterol with single-pill amlodipine/atorvastatin: a pooled analysis of patients with and without diabetes

Bibliografski detalji
Glavni autori:	Jenssen, T, Aguilar-Salinas, C, Hobbs, R, Feldman, R, Blank, R, Moller, R, Schou, I, Shi, H
Format:	Journal article
Izdano:	2008

Reduction in Blood Pressure and Low-Density Lipoprotein Cholesterol When Single-Pill Amlodipine/Atorvastatin is Used as First-Line or Add-On Treatment
od: Flack, J, i dr.
Izdano: (2009)

A Comparison of Blood Pressure and Low-Density Lipoprotein Cholesterol Reduction After Treatment With Single-Pill Amlodipine/Atorvastatin in Younger (Less Than 65 Years) and Older (65 Years or More) Men and Women Results of a Pooled Analysis of 5559 Patients
od: Hobbs, R, i dr.
Izdano: (2009)

A single-pill combination of amlodipine besylate and atorvastatin calcium (update).
od: Blank, R, i dr.
Izdano: (2007)

Utility of single-pill amlodipine besylate/atorvastatin calcium to help Asian patients with hypertension and dyslipidemia achieve blood pressure and lipid goals: Results of a pooled analysis
od: Tse, H, i dr.
Izdano: (2007)

A Comparison of Blood Pressure and Low-Density Lipoprotein Cholesterol Reduction After Treatment With Single-Pill Amlodipine/Atorvastatin In Elderly (75 years or more) and Younger (less than 75 years) Patients: Results of a Posted Analysis of 5559 Patients
od: Feldman, R, i dr.
Izdano: (2009)

Cost-effectiveness analysis of low density lipoprotein cholesterol-lowering therapy in hypertensive patients with type 2 diabetes in Korea: single-pill regimen (amlodipine/atorvastatin) versus double-pill regimen (amlodipine+atorvastatin)
od: Ji-Hyun Park, i dr.
Izdano: (2015-02-01)

Utility of amlodipine/atorvastatin single-pill therapy in patients with diabetes mellitus or metabolic syndrome: Results from the JEWEL programme
od: Hobbs, R, i dr.
Izdano: (2006)

Adherence with single-pill amlodipine/atorvastatin vs a two-pill regimen
od: Bimal V Patel, i dr.
Izdano: (2008-06-01)

Impact of age and gender on blood pressure and low-density lipoprotein cholesterol reduction: results of a pooled analysis.
od: Feldman, R, i dr.
Izdano: (2012)

International open-label studies to assess the efficacy and safety of single-pill amlodipine/atorvastatin in attaining blood pressure and lipid targets recommended by country-specific guidelines: the JEWEL programme.
od: Richard Hobbs, F, i dr.
Izdano: (2009)

Efficacy and Safety of a Single-Pill Combination of Atorvastatin/Amlodipine in Patients with Arterial Hypertension and Dyslipidemia
od: Stefan Naydenov Naydenov, i dr.
Izdano: (2018-01-01)

Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? The single pill of amlodipine/atorvastatin.
od: Hobbs, F
Izdano: (2007)

Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? The single pill of amlodipine/atorvastatin
od: FD Richard Hobbs
Izdano: (2007-11-01)

Relationship of High‐Density Lipoprotein Cholesterol With Renal Function in Patients Treated With Atorvastatin
od: Kwok Leung Ong, i dr.
Izdano: (2018-01-01)

Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? Rationale and design for an international, open-label program to assess the effectiveness of a single pill (amlodipine/atorvastatin) to attain recommended target levels for blood pressure and lipids (The JEWEL Program).
od: Hobbs, F, i dr.
Izdano: (2006)

Hypocholesterolemic actions of atorvastatin are associated with alterations on hepatic cholesterol metabolism and lipoprotein composition in the guinea pig
od: K Conde, i dr.
Izdano: (1996-11-01)

Plasma concentration of atorvastatin metabolites correlates with low‐density lipoprotein cholesterol reduction in patients with coronary heart disease
od: E. Sverre, i dr.
Izdano: (2023-06-01)

Comparative study of the effect of atorvastatin and fenofibrate on high-density lipoprotein cholesterol levels in patients with type 2 diabetes
od: Mostafa Najafipour, i dr.
Izdano: (2018-01-01)

Assessing the Accuracy of Estimated Lipoprotein(a) Cholesterol and Lipoprotein(a)‐Free Low‐Density Lipoprotein Cholesterol
od: Weili Zheng, i dr.
Izdano: (2022-01-01)

Management of triglycerides, non-high density lipoprotein cholesterol and high density lipoprotein cholesterol
od: Geevar Zachariah
Izdano: (2024-03-01)

Decreased production of low density lipoprotein by atorvastatin after apheresis in homozygous familial hypercholesterolemia
od: A D Marais, i dr.
Izdano: (1997-10-01)

Factors influencing drug switching and changes in low-density lipoprotein-cholesterol levels with atorvastatin: a real-world observational study
od: Yu-Cheol Lim, i dr.
Izdano: (2023-09-01)

Monocyte/high-density lipoprotein cholesterol, neutrophil/high-density lipoprotein cholesterol, and lymphocyte/high-density lipoprotein cholesterol ratios as new inflammatory markers in rosacea
od: Bülent Nuri Kalaycı
Izdano: (2023-06-01)

Therapeutic Options for the Single Pill Combination of Lisinopril, Amlodipine and Rosuvastatin: a Systematic Review
od: S. R. Gilyarevsky, i dr.
Izdano: (2022-09-01)

Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
od: Niki Katsiki, i dr.
Izdano: (2023-04-01)

Effects of Atorvastatin, Amlodipine, and Their Combination on Vascular Dysfunction in Insulin-Resistant Rats
od: Tomio Okamura, i dr.
Izdano: (2014-01-01)

Effects of amlodipine and atorvastatin on endothelial vasoactive mediators in patients with metabolic syndrome
od: N V Blinova, i dr.
Izdano: (2015-03-01)

Comparison of ten formulae for calculating low-density lipoprotein cholesterol with direct low-density lipoprotein cholesterol measurement
od: Suriyan S. Nair, i dr.
Izdano: (2024-10-01)

The relationship between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and hyperuricaemia
od: Zhaoxiang Wang, i dr.
Izdano: (2024-06-01)

The ratio of low-density lipoprotein cholesterol to apolipoprotein-B as a marker of low-density lipoprotein particle size
od: A. M. Kaneva, i dr.
Izdano: (2018-06-01)

Pleiotropic vasoprotective effects of high-dose atorvastatin therapy in the context of achieving the target low-density lipoprotein cholesterol in patients after myocardial infarction
od: L. I. Salyamova, i dr.
Izdano: (2022-08-01)

Fixed triple combination of amlodipine, perindopril and atorvastatin in the focus of cardiovascular effectiveness and safety
od: A. N. Kuchmin, i dr.
Izdano: (2023-10-01)

Severe Rhabdomyolysis due to Presumed Drug Interactions between Atorvastatin with Amlodipine and Ticagrelor
od: Iouri Banakh, i dr.
Izdano: (2017-01-01)

Low‐Density Lipoprotein Cholesterol Corrected for Lipoprotein(a) Cholesterol, Risk Thresholds, and Cardiovascular Events
od: Peter Willeit, i dr.
Izdano: (2020-12-01)

Association of cumulative non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio with the risk of cardiometabolic disease
od: Luqing Liu, i dr.
Izdano: (2024-11-01)

Association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and sarcopenia based on NHANES
od: Ma Yanming, i dr.
Izdano: (2024-12-01)

Utility of Non-High-Density Lipoprotein Cholesterol to High-Density Lipoprotein Cholesterol Ratio in Evaluating Incident Diabetes Risk
od: Sheng G, i dr.
Izdano: (2022-05-01)

Impact of low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio on the risk factors for and outcome of ischemic stroke
od: Xin-wei BI, i dr.
Izdano: (2014-10-01)

Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low‐Density Lipoprotein Cholesterol or Non‐High‐Density Lipoprotein Cholesterol
od: Allan D. Sniderman, i dr.
Izdano: (2016-10-01)

Prolonged inhibition of cholesterol synthesis explains the efficacy of atorvastatin
od: R P Naoumova, i dr.
Izdano: (1997-07-01)

Control of blood pressure and low-density lipoprotein cholesterol with single-pill amlodipine/atorvastatin: a pooled analysis of patients with and without diabetes

Slični predmeti

Slični predmeti